Viewing nowCombinationAmstel Tablets 40/10 mg
Telmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
IQURE Co., Ltd.

MFDS item code 201605747 · Approved 2016.09.30 · Insurance code 674401340
Treatment of essential hypertension not controlled with monotherapy
This medication is prescribed for patients with essential hypertension whose blood pressure is not adequately controlled by monotherapy with telmisartan or amlodipine, allowing for more effective blood pressure control. This helps reduce the risk of complications associated with hypertension and improves overall cardiovascular health. It is used to manage blood pressure consistently, enhancing the quality of life for patients.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the doses of the individual components (amlodipine or telmisartan) be adjusted before starting this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients for whom this medicine should be administered with caution’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus, especially during the second and third trimester of pregnancy, therefore, it should not be taken by women who are pregnant or may become pregnant. Patients who are allergic to the active ingredient or similar compounds, those with severe liver dysfunction, severe heart disease, acute myocardial infarction, or specific kidney disorders should not be given this medication. Patients with compromised liver or heart function, gastrointestinal disorders, renal artery stenosis, and the elderly should use this medication with special caution. During treatment with this medication, side effects such as dizziness or swelling may frequently occur, and in severe cases, fainting or heart-related issues could arise, necessitating immediate consultation with a physician if any abnormal symptoms occur. Use of this medication should be avoided during pregnancy, and if pregnancy is confirmed, discontinuation should occur as soon as possible. Additionally, it is recommended that breastfeeding women do not take this medication. Patients with excessively low blood pressure or unstable heart function, and those taking certain medications concurrently, may experience interactions, so consultation with a physician is mandatory. As this medication lowers blood pressure, caution should be exercised while driving or operating dangerous machinery due to risks of drowsiness or dizziness during treatment. In cases of overdose, symptoms such as hypotension, dizziness, and arrhythmias may occur, necessitating immediate medical attention for appropriate treatment. Special care is needed for children or the elderly, especially for the elderly, starting at a low dose and gradually increasing it for safety. This medication is sensitive to moisture, so it should be stored in a dry place out of reach of children, and transferring it to other containers should be avoided.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light; therefore, it should be stored in a container that does not allow light in. Also, to maintain the medication's efficacy, it should be stored at room temperature, ideally between 1 degrees and 30 degrees Celsius.
White and light blue, double convex, oval-shaped tablets
30 tablets (10 tablets/PTP*3), 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
IQURE Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.